On the 12 January 2016, Rorine International Holding Corporation Inc. successfully entered in a marketing and distribution agreement with RICH Group based in South East Asia. The agreement was negotiated and announced by Rorine's Chief Financial Officer Mr. Tan Sew. This agreement has taken several months to plan and negotiate and “will give Rorine an opportunity to market Eastern alternative medical packages related to Type II Diabetes outside of China to non-traditional markets such as in the West.

According to this agreement, Rorine will setup and prepare a marketing strategy and platform as well as liaise with hospitals, clinics and associations in order to bring this unique product to markets in the West where Diabetes is also on the rise.